Literature DB >> 26776828

National Cancer Center Singapore: the way forward.

Melissa Teo1, Khee Chee Soo2.   

Abstract

Cancer is the leading cause of death in Singapore, comprising almost 30% of annual deaths. The incidence and prevalence continue to rise, resulting in Singapore having the highest age-standardized rate of cancer in southeast Asia. A review of national health policies in 1992 resulted in the creation of a National Cancer Centre Singapore (NCCS) in 1999. The current NCCS, with its three pillars of clinical service, research and education, manages about 70% of all new cancer cases in the countries public healthcare system. As it outgrows its current outfit and looks to the new NCCS building in 2020, the goal must be for strategic planning to attract and retain the best minds and heart in the field of cancer if it were to continue to be successful in achieving its vision and mission. This article chronicles the NCCS's history and details the foundation of its strategic plans.

Entities:  

Keywords:  Comprehensive Cancer Center; National Cancer Center Singapore; future standard in cancer care

Mesh:

Year:  2016        PMID: 26776828     DOI: 10.2217/fon.15.331

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  2 in total

1.  Trajectories of Health-related quality of life in patients with Advanced Cancer during the Last Year of Life: findings from the COMPASS study.

Authors:  Jonathan Lee; Mahham Shafiq; Rahul Malhotra; Semra Ozdemir; Irene Teo; Chetna Malhotra
Journal:  BMC Palliat Care       Date:  2022-10-14       Impact factor: 3.113

2.  Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre.

Authors:  Jianbang Chiang; Valerie Shiwen Yang; Shuting Han; Qingyuan Zhuang; Gideon Ooi; Iris Huili Sin; Gail Wan Ying Chua; Si Ying Tan; Claramae Shulyn Chia; Veronique Kiak-Mien Tan; Patricia Soek Hui Neo; Jin Wei Kwek; Swee Peng Yap; Ravindran Kanesvaran; Soon Thye Lim; William Ying Khee Hwang; Chee Kian Tham
Journal:  J Cancer Policy       Date:  2020-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.